Orifarm GmbH is a pharmaceutical import and supply company based in Leverkusen, Germany, and part of the Danish parent company Orifarm. Its core business is not SaaS or enterprise software; instead, it supplies medicines to German pharmacies, wholesalers, hospitals, and research institutions in the European healthcare market through EU parallel imports of originator drugs, individual imports, and procurement of medicines for clinical trials. The website states that it offers more than 1,700 preparations in Germany, has around 250 employees in Leverkusen, and generates annual revenue of approximately €700 million.
From an enterprise software perspective, the available information is limited. Its business modules include parallel-imported medicines, individual imports under AMG §73(3), the Carefarm and Aaragon sales brands, procurement of comparator drugs and concomitant medication for clinical trials, a pharmacy customer service center, and Oriculum training materials. In terms of digital interfaces, the text explicitly mentions MSV3: pharmacies can configure it in their Warenwirtschaftssystem (goods/inventory management system) for fast ordering. There is also a DocCheck download area offering service documents and product catalogs. Beyond that, there is no disclosed information on APIs, developer documentation, permission management, cloud deployment, or self-hosting capabilities.
There are no SaaS subscription plans or free trials here. Pricing information mainly concerns supply terms for pharmacies: almost all categories are priced at APU + €0.73; products with an APU below €1,200 receive a 3.15% wholesale markup discount; high-priced medicines with an APU above €1,200 receive a fixed full-pack subsidy of €37.80; and orders of €100 or more qualify for free next-business-day shipping. Customer support is available Monday to Friday, 08:00–18:30, with orders accepted by phone or fax.
The strengths are a clear pharmaceutical supply network, broad category coverage, and the ability to handle specialized scenarios such as parallel imports, shortage medicines, and clinical trial supply. It also provides pharmacies with MSV3 ordering, return rights, and clearly defined customer service channels. The downside is that it is not a software product and lacks the plans, permissions, collaboration features, APIs, security certifications, and deployment information commonly expected from SaaS products, making it impossible to assess as enterprise software in a full sense.
It is better suited to participants in the German and European pharmaceutical supply chain, especially pharmacies, pharmaceutical wholesalers, hospital procurement teams, and clinical trial teams. For Chinese users, applicability is mainly constrained by pharmaceutical import regulations, cross-border qualifications, prescription rules, and supply-chain compliance requirements. The text does not state whether the website is accessible from mainland China, and payment methods are not disclosed. For China-based operations, it is preferable to choose a pharmaceutical supply-chain service provider with domestic drug distribution, import registration, and compliance qualifications.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on orifarm.de official site.
orifarm.de is an Denmark SaaS Tools provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach orifarm.de directly.